Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing BioKangjian Pharmaceutical is a specialized pharmaceutical enterprise based in Beijing, China, focusing on the research, development, and commercialization of high-quality medicines. Established in 2003, the company has built a strong reputation in the fields of anti-viral therapy, particularly for chronic Hepatitis B, and cardiovascular health. Its commercial portfolio includes key products such as Adefovir Dipivoxil and Entecavir, which are essential treatments in the Chinese healthcare market. BioKangjian maintains modern, GMP-certified manufacturing bases and a dedicated R&D center to support its pipeline of generic and innovative drugs. The company is committed to providing cost-effective therapeutic solutions while advancing its technological capabilities in drug formulation and synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing BioKang Jian.